This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Curatola, A M Articles by Basilico, C Search for Related Content PubMed PubMed Citation Articles by Curatola, A M Articles by Basilico, C

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 June; 10(6): 2475-2484

Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.

Department of Pathology, New York University School of Medicine, New York 10016.

ABSTRACT

Expression of the K-fgf/hst proto-oncogene appears to be restricted to cells in the early stages of development, such as embryonal carcinoma (EC) cells. When EC cells are induced to differentiate, K-fgf expression is drastically repressed. To identify cis-acting DNA elements responsible for this type of regulation, we constructed a plasmid in which cat gene expression was driven by about 1 kilobase of upstream K-fgf human DNA sequences, including the putative promoter, and transfected it into undifferentiated F9 EC cells or HeLa cells as prototypes of cells which express or do not express, respectively, the K-fgf proto-oncogene. This plasmid was essentially inactive in both cell types, and the addition of more than 8 kilobases of DNA sequences upstream of the K-fgf promoter did not lead to any increase in chloramphenicol acetyltransferase (CAT) expression. On the other hand, when we inserted in this plasmid DNA sequences which are 3' of the human K-fgf coding sequences, we could detect a significant stimulation of CAT activity. Analysis of these sequences led to the identification of enhancerlike DNA elements which are part of the 3' noncoding region of K-fgf exon 3 and promote CAT expression only in undifferentiated mouse F9 or human NT2/D1 EC cells, but not in HeLa, 3T3, or differentiated F9 cells, therefore mimicking the physiological expression of the K-fgf proto-oncogene. Similar elements are also present in the 3' region of the murine K-fgf proto-oncogene, in a region showing high homology to the human K-fgf sequences. These regulatory elements can promote CAT expression from heterologous promoters in an EC-specific manner, suggesting that they interact with a specific cellular transacting protein(s) whose expression is developmentally regulated.

This article has been cited by other articles:

• Yaragatti, M., Basilico, C., Dailey, L. (2008). Identification of active transcriptional regulatory modules by the functional assay of DNA from nucleosome-free regions. Genome Res 18: 930-938 [Abstract] [Full Text]  
• Wiebe, M. S., Nowling, T. K., Rizzino, A. (2003). Identification of Novel Domains within Sox-2 and Sox-11 Involved in Autoinhibition of DNA Binding and Partnership Specificity. J. Biol. Chem. 278: 17901-17911 [Abstract] [Full Text]  
• Nowling, T., Bernadt, C., Johnson, L., Desler, M., Rizzino, A. (2003). The Co-activator p300 Associates Physically with and Can Mediate the Action of the Distal Enhancer of the FGF-4 Gene. J. Biol. Chem. 278: 13696-13705 [Abstract] [Full Text]  
• Johnson, L. R., Johnson, T. K., Desler, M., Luster, T. A., Nowling, T., Lewis, R. E., Rizzino, A. (2002). Effects of B-Myb on Gene Transcription. PHOSPHORYLATION-DEPENDENT ACTIVITY AND ACETYLATION BY p300. J. Biol. Chem. 277: 4088-4097 [Abstract] [Full Text]  
• Pesce, M., Scholer, H. R. (2001). Oct-4: Gatekeeper in the Beginnings of Mammalian Development. Stem Cells 19: 271-278 [Abstract] [Full Text]  
• Nowling, T. K., Johnson, L. R., Wiebe, M. S., Rizzino, A. (2000). Identification of the Transactivation Domain of the Transcription Factor Sox-2 and an Associated Co-activator. J. Biol. Chem. 275: 3810-3818 [Abstract] [Full Text]  
• Moon, A., Boulet, A., Capecchi, M. (2000). Normal limb development in conditional mutants of Fgf4. Development 127: 989-996 [Abstract]  
• Madiai, F., Hackshaw, K. V., Chiu, I.-M. (1999). Characterization of the Entire Transcription Unit of the Mouse Fibroblast Growth Factor 1 (FGF-1) Gene. TISSUE-SPECIFIC EXPRESSION OF THE FGF-1.A mRNA. J. Biol. Chem. 274: 11937-11944 [Abstract] [Full Text]  
• Gemel, J., Jacobsen, C., MacArthur, C. A. (1999). Fibroblast Growth Factor-8 Expression Is Regulated by Intronic Engrailed and Pbx1-binding Sites. J. Biol. Chem. 274: 6020-6026 [Abstract] [Full Text]  
• Botquin, V., Hess, H., Fuhrmann, G., Anastassiadis, C., Gross, M. K., Vriend, G., Schöler, H. R. (1998). New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 12: 2073-2090 [Abstract] [Full Text]  
• Yuan, H, Corbi, N, Basilico, C, Dailey, L (1995). Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.. Genes Dev. 9: 2635-2645 [Abstract]  
• Myers, R. L., Ray, S. K., Eldridge, R., Chotani, M. A., Chiu, I.-M. (1995). Functional Characterization of the Brain-specific FGF-1 Promoter, FGF-1.B. J. Biol. Chem. 270: 8257-8266 [Abstract] [Full Text]  
• Feldman, B, Poueymirou, W, Papaioannou, V., DeChiara, T., Goldfarb, M (1995). Requirement of FGF-4 for postimplantation mouse development. Science 267: 246-249 [Abstract]  
• Rappolee, D., Basilico, C, Patel, Y, Werb, Z (1994). Expression and function of FGF-4 in peri-implantation development in mouse embryos. Development 120: 2259-2269 [Abstract]  
• Ambrosetti, D.-C., Scholer, H. R., Dailey, L., Basilico, C. (2000). Modulation of the Activity of Multiple Transcriptional Activation Domains by the DNA Binding Domains Mediates the Synergistic Action of Sox2 and Oct-3 on the Fibroblast Growth Factor-4 Enhancer. J. Biol. Chem. 275: 23387-23397 [Abstract] [Full Text]